肾小球疾病患者流感疫苗接种实施与效果
本研究利用美国商业保险数据库,观察2010至2019年确诊原发性肾小球疾病的儿童和65岁以下成人,评估流感疫苗接种率及对流感样疾病的效果。结果显示每季平均接种率仅23%,匹配季节接种对流感(RHR 0.86,95%CI 0.52-1.41)和流感样疾病(RHR 0.86,95%CI 0.59-1.24)保护作用有限,受样本量限制。
要点
- 肾小球疾病患者流感疫苗接种率低,每季平均仅23%。
- 匹配季节接种对流感及流感样疾病的保护作用有限。
- 该人群疫苗保护可能不足,需关注感染相关疾病负担。
核心结论
- 肾小球疾病患者流感疫苗接种率不理想,接种后保护效果可能较差。
研究设计与样本
- 观察性队列研究,使用Merative MarketScan商业保险索赔数据,纳入2010至2019年确诊原发性肾小球疾病的儿童和65岁以下成人。
主要发现
- 每季平均接种比例为23%(范围19%-24%)。
- 匹配季节接种对流感风险RHR为0.86(95%CI 0.52-1.41)。
- 匹配季节接种对流感样疾病风险RHR为0.86(95%CI 0.59-1.24)。
临床怎么用
- 应关注肾小球疾病患者流感疫苗接种率低的现状。
- 接种后仍需警惕流感及流感样疾病发生。
局限性
- 估计值受样本量限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Influenza infections contribute to excess healthcare utilization, morbidity, and mortality in individuals with glomerular disease (GD); however, influenza vaccination may not yield protective immune responses in this high-risk patient population. The objective of the present study was to describe influenza vaccine administration from 2010 to 2019 and explore the effectiveness of influenza vaccination in patients with GD. METHODS: We conducted an observational cohort study using healthcare claims for seasonal influenza vaccination (exposure) as well as influenza and influenza-like illness (outcomes) from commercially insured children and adults <65 years of age with primary GD in the Merative MarketScan Research Databases. Propensity score-weighted cox proportional hazards models and ratio-of-hazard ratios (RHR) analyses were used to compare influenza infection risk in years where seasonal influenza vaccines matched or mismatched circulating viral strains. RESULTS: The mean proportion of individuals vaccinated per season was 23% (range 19%-24%). In pooled analyses comparing matched to mismatched seasons, vaccination was minimally protective for both influenza (RHR 0.86, 95% confidence interval [CI]: 0.52-1.41) and influenza-like illness (RHR 0.86, 95% CI 0.59-1.24), though estimates were limited by sample size. CONCLUSION: Rates of influenza vaccination are suboptimal among patients with GD. Protection from influenza after vaccination may be poor, leading to excess infection-related morbidity in this vulnerable population.
引用
- Glenn DA, Pate V, Zee J, et al. Influenza Vaccine Administration and Effectiveness Among Children and Adults With Glomerular Disease. Kidney Int Rep. 2023. PMID: 38344741. doi:10.1016/j.ekir.2023.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。